tiprankstipranks
Advertisement
Advertisement

NRIX Stock Latest News

Nurix Maintained at Buy as Bexobrutideg Data Underscore Safety Edge; $34 Price Target Reaffirmed
RatingsNurix Maintained at Buy as Bexobrutideg Data Underscore Safety Edge; $34 Price Target Reaffirmed
2d ago
NRIX
Nurix Highlights Promising Phase 1b Data for Bexobrutideg
PremiumCompany Announcements
Nurix Highlights Promising Phase 1b Data for Bexobrutideg
6d ago
8K
NRIX
Nurix Therapeutics price target raised to $32 from $30 at Truist
PremiumThe Fly
Nurix Therapeutics price target raised to $32 from $30 at Truist
7d ago
NRIX
Nurix Therapeutics price target raised to $32 from $30 at BTIG
PremiumThe Fly
Nurix Therapeutics price target raised to $32 from $30 at BTIG
8d ago
NRIX
Morgan Stanley’s Terence Flynn Reiterates Buy on Nurix, Citing Value-Creating Roche Partnership and Long‑Term Bexobrutideg Growth Potential
PremiumRatings
Morgan Stanley’s Terence Flynn Reiterates Buy on Nurix, Citing Value-Creating Roche Partnership and Long‑Term Bexobrutideg Growth Potential
8d ago
NRIX
Nurix Therapeutics price target raised to $32 from $30 at Truist
PremiumThe FlyNurix Therapeutics price target raised to $32 from $30 at Truist
8d ago
CHRO
NRIX
Nurix Therapeutics price target raised to $45 from $41 at Jefferies
Premium
The Fly
Nurix Therapeutics price target raised to $45 from $41 at Jefferies
8d ago
CHRO
NRIX
Nurix Therapeutics price target raised to $34 from $26 at Needham
Premium
The Fly
Nurix Therapeutics price target raised to $34 from $26 at Needham
8d ago
NRIX
Nurix Therapeutics downgraded to Equal Weight at Wells Fargo after Roche deal
PremiumThe Fly
Nurix Therapeutics downgraded to Equal Weight at Wells Fargo after Roche deal
8d ago
CHRO
NRIX
Nurix Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe Fly
Nurix Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
8d ago
NRIX
Video: Marvell, Flex rise after selection for S&P 500
PremiumThe Fly
Video: Marvell, Flex rise after selection for S&P 500
8d ago
CPB
LLY
Morning Movers: Corning jumps after optical supply deal with Amazon
PremiumThe Fly
Morning Movers: Corning jumps after optical supply deal with Amazon
8d ago
CPB
GHM
Nurix and Roche forge global BTK degrader alliance
PremiumCompany AnnouncementsNurix and Roche forge global BTK degrader alliance
9d ago
8K
NRIX
Nurix Therapeutics Stock (NRIX) Soars 40% After $2.3B Blood Cancer Deal with Roche
Premium
Market News
Nurix Therapeutics Stock (NRIX) Soars 40% After $2.3B Blood Cancer Deal with Roche
9d ago
NRIX
Nurix Therapeutics teams with Roche to develop, commercialize bexobrutideg
Premium
The Fly
Nurix Therapeutics teams with Roche to develop, commercialize bexobrutideg
9d ago
CHRO
NRIX
Nurix Therapeutics Shareholders Back Directors and Governance Proposals
PremiumCompany Announcements
Nurix Therapeutics Shareholders Back Directors and Governance Proposals
1M ago
8K
NRIX
Gil Blum Reiterates Buy on Nurix, Maintains $26 Price Target on Advancing Degrader Pipeline
PremiumRatings
Gil Blum Reiterates Buy on Nurix, Maintains $26 Price Target on Advancing Degrader Pipeline
1M ago
NRIX
Analyst Reiterates Buy on Nurix, Maintains $32 Price Target on Strength of Degrader Platform and Pipeline
PremiumRatings
Analyst Reiterates Buy on Nurix, Maintains $32 Price Target on Strength of Degrader Platform and Pipeline
2M ago
NRIX
Buy Rating on Nurix Therapeutics Backed by Strong Clinical Momentum, Strategic Execution, and Attractive Risk‑Reward Profile
PremiumRatings
Buy Rating on Nurix Therapeutics Backed by Strong Clinical Momentum, Strategic Execution, and Attractive Risk‑Reward Profile
2M ago
NRIX
Nurix Therapeutics price target lowered to $28 from $29 at Wells Fargo
PremiumThe FlyNurix Therapeutics price target lowered to $28 from $29 at Wells Fargo
2M ago
NRIX
Nurix Therapeutics price target lowered to $34 from $35 at Stifel
Premium
The Fly
Nurix Therapeutics price target lowered to $34 from $35 at Stifel
2M ago
NRIX
Nurix Therapeutics: Buy Rating Backed by Advancing Bexobrutideg Program, Sanofi STAT6 Milestones, and Solid Cash Runway
Premium
Ratings
Nurix Therapeutics: Buy Rating Backed by Advancing Bexobrutideg Program, Sanofi STAT6 Milestones, and Solid Cash Runway
2M ago
NRIX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >